Publication | Closed Access

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors

Hematological MalignancySolid TumorsMedicineReceptor Tyrosine KinaseImmunologyTherapeutic StrategyMultiple MyelomaRadiation OncologyOncologyCell BiologyCancer ResearchCancer Growth